Dr. Jinglin Fu is awarded a “NIH R15 on Enhancement of Genome Editing in Hematopoietic Stem Cells by Nucleic Acids Nanoparticles Delivery of CRISPR/CAS System”.

Posted by Jinglin Fu in What's New?.

In February 2025, Dr. Jinglin Fu was awarded an “NIH R15 on Enhancement of Genome Editing in Hematopoietic Stem Cells by Nucleic Acids Nanoparticles Delivery of CRISPR/CAS System”. This is a collaborative research project with the Coriell Institute of Medical Research and will provide biomedical training opportunities for students at Rutgers Camden.